SUSAN HILSENBECK to Clinical Trials, Phase I as Topic
This is a "connection" page, showing publications SUSAN HILSENBECK has written about Clinical Trials, Phase I as Topic.
Connection Strength
0.129
-
Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials. Clin Cancer Res. 2016 Sep 01; 22(17):4291-301.
Score: 0.129